LISATA THERAPEUTICS, INC. financial data

Symbol
LSTA on Nasdaq
Location
Basking Ridge, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 589% % -27%
Debt-to-equity 20% % 44%
Return On Equity -86% % -53%
Return On Assets -71% % -45%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,032,291 shares 4.8%
Common Stock, Shares, Outstanding 8,833,875 shares 5.1%
Entity Public Float $23,600,000 USD -15%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 8,687,000 shares 4.3%
Weighted Average Number of Shares Outstanding, Diluted 8,687,000 shares 4.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $170,000 USD -83%
Operating Income (Loss) $18,209,000 USD 19%
Nonoperating Income (Expense) $661,000 USD -59%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $17,548,000 USD 16%
Income Tax Expense (Benefit) $962,000 USD -100%
Net Income (Loss) Attributable to Parent $16,586,000 USD 17%
Earnings Per Share, Basic -1.91 USD/shares 20%
Earnings Per Share, Diluted -1.91 USD/shares 20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $15,956,000 USD -1.6%
Cash, Cash Equivalents, and Short-term Investments $14,492,000 USD -52%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD -100%
Assets, Current $17,703,000 USD -49%
Property, Plant and Equipment, Net $18,000 USD -75%
Operating Lease, Right-of-Use Asset $0 USD -100%
Intangible Assets, Net (Excluding Goodwill) $400,000 USD 0%
Other Assets, Noncurrent $23,000 USD -86%
Assets $17,744,000 USD -49%
Accounts Payable, Current $1,019,000 USD -21%
Employee-related Liabilities, Current $812,000 USD -69%
Accrued Liabilities, Current $2,052,000 USD -53%
Liabilities, Current $3,071,000 USD -45%
Operating Lease, Liability, Noncurrent $0 USD
Other Liabilities, Noncurrent $72,000 USD 0%
Liabilities $3,143,000 USD -45%
Accumulated Other Comprehensive Income (Loss), Net of Tax $37,000 USD 54%
Retained Earnings (Accumulated Deficit) $564,652,000 USD -3%
Stockholders' Equity Attributable to Parent $14,855,000 USD -50%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $14,601,000 USD -50%
Liabilities and Equity $17,744,000 USD -49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,402,000 USD 23%
Net Cash Provided by (Used in) Financing Activities $23,000 USD 84%
Net Cash Provided by (Used in) Investing Activities $9,431,000 USD 47%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 8,834,613 shares 5.1%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,008,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,956,000 USD -1.6%
Deferred Tax Assets, Valuation Allowance $30,885,000 USD 11%
Deferred Tax Assets, Gross $30,885,000 USD 11%
Operating Lease, Liability $0 USD -100%
Depreciation $26,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $28,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $16,542,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid $0 USD -100%
Property, Plant and Equipment, Gross $494,000 USD -25%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One $143,000 USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards $27,016,000 USD 68%
Unrecognized Tax Benefits $344,000 USD 0%
Additional Paid in Capital $580,243,000 USD 0.32%
Amortization of Intangible Assets $65,000 USD -8.5%
Deferred Tax Assets, Net of Valuation Allowance $30,885,000 USD 11%
Share-based Payment Arrangement, Expense $1,226,000 USD -26%